skip to primary navigationskip to content

Revised clinical guidelines for treating cancer patients during COVID-19 pandemic

last modified Apr 20, 2020 04:11 PM

Professor Richard Gilbertson (Head of Department of Oncology and Director of CRUK Cambridge Centre) would like to bring to your attention an important paper  recently published in Nature Medicine, co-authored by Carlos Caldas (Department of Oncology), .

Photo of Carlos CaldasCambridge and six other leading cancer centres across Europe have shared their knowledge and experiences to define new guidelines for treating cancer patients during the COVID-19 pandemic.

Despite operating within different healthcare systems and central policies in their respective countries, the alliance of seven leading cancer centres (known as Cancer Core Europe), have collated and compared the treatment guidelines they have rapidly put in place to limit hospital visits and admissions, and reduce immune-related complications due to cancer treatments, without compromising patient outcomes.

It is an amazing achievement to produce this roadmap in such a short time and we would especially like to acknowledge and thank the many clinical staff at Addenbrooke’s Hospital who have contributed their expertise across multiple disciplines (surgery, radiology, pathology, radiation oncology and medical oncology), including: Jean Abraham, Thankamma Ajithkumar, Richard Baird, Gill Barnett, Emma Beddowes, Richard Benson, Charlotte Coles, Pippa Corrie, Gary Doherty, Hugo Ford, David Gilligan, Luke Hughes-Davies, Ekpemi Irune, Rashmi Jadon, Sarah Jefferies, Siong-Seng Liau, Karen McAdam, Paul Pharoah, Elizabeth Smyth, Elizabeth Tweedie and Charles Wilson.

We hope that our collective experiences will help guide others and will also reassure cancer patients that we are doing everything we can to avoid compromising the quality of their cancer care in these unsettling times.